About: Historical Aspects of Polyclonal IgG Preparations

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Historical Aspects of Polyclonal IgG Preparations Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Historical Aspects of Polyclonal IgG Preparations
Creator	Späth, Peter Späth, P Wahn, Volker Wahn, V
Source	PMC
abstract	Today we can choose between several polyclonal IgG products for both replacement and immunomodulation. However, it was a long way to go to reach this stage. In this chapter, we try to illustrate the major stages of IgG product development which began more than 70 years ago.
has issue date	2017-09-06(xsd:dateTime)
bibo:doi	10.1007/978-3-319-68038-5_10
has license	no-cc
sha1sum (hex)	439f3b9d4cdb205d177e860516dae4159cbb1e60
schema:url	https://doi.org/10.1007/978-3-319-68038-5_10
resource representing a document's title	Historical Aspects of Polyclonal IgG Preparations
has PubMed Central identifier	PMC7123136
schema:publication	Antibody Therapy
resource representing a document's body	covid:439f3b9d4cdb205d177e860516dae4159cbb1e60#body_text
is schema:about of	named entity 'Preparations' named entity 'Historical' named entity 'IgG' named entity 'gamma globulin' named entity 'IgG' named entity 'MMN' named entity 'Aseptic meningitis' named entity 'subcutaneous' named entity 'Cherin' named entity 'Boston' named entity 'HCV' named entity 'IgG' named entity 'IgG' named entity 'Anion exchange chromatography' named entity 'Thrombosis' named entity 'antibodies' named entity 'treat patients' named entity 'Hemolysis' named entity 'C3a' named entity 'virus transmission' named entity 'IgG' named entity 'ethanol' named entity 'prophylaxis' named entity 'autoimmune' named entity 'IgG' named entity 'IgG' named entity 'pseudohyponatremia' named entity 'clinical trials' named entity 'WHO' named entity 'Office of Scientific Research and Development' named entity 'IgG' named entity 'American Red Cross' named entity 'IgG' named entity 'IVIG' named entity 'biological activity' named entity 'anaphylactoid reactions' named entity 'risk factors' named entity 'IgG' named entity 'fractionating' named entity 'virus' named entity 'IVIG' named entity 'IgG' named entity 'intramuscular injection' named entity 'hepatitis' named entity 'serum' named entity 'factor XI' named entity 'intravenous' named entity 'serum' named entity 'immunoglobulin' named entity 'IgG' named entity 'coevolution' named entity 'plasma' named entity 'human albumin' named entity 'dermatological' named entity 'isohemagglutinin' named entity 'plasma' named entity 'IgG' named entity 'HCV' named entity 'anti-D immunoglobulin' named entity 'intravenous' named entity 'HCV' named entity 'homologous' named entity 'anti-D' named entity 'intravenous injection' named entity 'Prekallikrein' named entity 'serum' named entity 'IgG' named entity 'blood donor' named entity 'Masuho' named entity 'Harvard Medical School' named entity 'immunoglobulins' named entity 'Peter Bent Brigham Hospital' named entity 'ITP' named entity 'Hyponatremia' named entity 'Cohn fraction II' named entity 'PKA' named entity 'pepsin' named entity 'antibody' named entity 'C5a' named entity 'subcutaneous'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software